Chlamydia pneumoniae seropositivity is associated with carotid artery intima-media thickness

Stroke

Volumn 31, Issue 7, 2000, Pages 1526-1531

  Schmidt, Caroline ^d   Hulthe, Johannes ^d   Wikstrand, John ^d   Gnarpe, Håkan ^b,c   Gnarpe, Judy ^b   Agewall, Stefan ^a   Fagerberg, Björn ^a,d  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^b GÄVLE HOSPITAL   (Sweden)

^c UPPSALA UNIVERSITY   (Sweden)

^d UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

Carotid arteries; Chlamydia

Indexed keywords

IMMUNOGLOBULIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M;

ADULT; AGED; ANTIBODY TITER; ANTIGEN ANTIBODY COMPLEX; ARTERY INTIMA PROLIFERATION; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CAROTID ARTERY; CHLAMYDOPHILA PNEUMONIAE; DIABETES MELLITUS; HUMAN; HYPERCHOLESTEROLEMIA; INFECTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR; SMOKING;

EID: 0033933270     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.31.7.1526     Document Type: Article

References (41)

1. Kuo C-c, Campbell LA, Grayston JT. Is infection with Chlamydia pneumoniae a causative agent in atherosclerosis? Mol Med Today. 1998;4: 426-430.
2. Grayston JT. Infections caused by Chlamydia pneumoniae strain TWAR. Clin Infect Dis. 1992;15:757-763.
3. Maas M, Krause E, Engel PM, Krüger S. Endovascular presence of Chlamydia pneumoniae in patients with hemodynamically effective carotid artery stenosis. Angiology. 1997;48:699-706.
4. Yamashita K, Ouch K, Shirai M, Gondo T, Nakazawa T, Ito H. Distribution of Chlamydia pneumoniae infection in the atherosclerotic artery. Stroke. 1998;29:773-778.
5. Falck G, Heyman L, Gnarpe J, Gnarpe H. Chlamydia pneumoniae and chronic pharyngitis. Scand J Infect Dis. 1995;27:179-182.
6. Falck G, Engstrand I, Gad A, Gnarpe J, Gnarpe H, Laurila A. Demonstration of Chlamydia pneumoniae in patients with chronic pharyngitis. Scand J Infect Dis. 1997;29:585-589.
7. Chiu B, Viira E, Tucker E, Fong I. W. Chlamydia pneumoniae, cytomegalovirus, and herpes simplex virus in atherosclerosis of the carotid artery. Circulation. 1997;96:2144-2148.
8. Juvonen J, Juvonen T, Laurila A, Alakärppä H, Lounatamaa K, Surcel H-M, Leinonen M, Kairaluoma MI, Saikku P. Demonstration of Chlamydia pneumoniae in the walls of abdominal aneurysms. J Vasc Surg. 1997;25:499-505.
9. Kuo C-c, Shor A, Campbell LA, Fukushi H, Patton DL, Grayston JT. Demonstration of Chlamydia pneumoniae in atherosclerotic lesions of coronary arteries. J Infect Dis. 1993;167:841-849.
10. Taylor-Robinson D. Chlamydia pneumoniae in vascular tissue. Atherosclerosis. 1998;140(suppl 1):S21-S24.
11. Linnanmäki E, Leinonen M, Mattila K, Neiminen MS, Valtonen V, Saikku P. Chlamydia pneumoniae-specific circulating immune complexes in patients with chronic coronary heart disease. Circulation. 1993; 87:1130-1134.
12. Cook PJ, Honeybourne D, Lip GYH, Beevers G, Wise R, Davies P. Chlamydia pneumoniae antibody titers are significantly associated with acute stroke and transient cerebral ischemia: the West Birmingham Stroke Project. Stroke. 1998;29:404-410.
13. Fagerberg B, Gnarpe J, Gnarpe H, Agewall S, Wikstrand J. Chlamydia pneumoniae but not cytomegalovirus antibodies are associated with future risk of stroke and cardiovascular disease: a prospective study in middle-aged to elderly men with treated hypertension. Stroke. 1999;29: 299-305.
14. Schmidt C, Wendelhag I. How can the variability in ultrasound measurement of intima-media thickness be reduced? Studies of interobserver variability in carotid and femoral arteries. Clin Physiol. 1999;19:45-55.
15. Suurküla M, Agewall S, Fagerberg B, Wendelhag I, Widgren B, Wikstrand J. Ultrasound evaluation of atherosclerotic manifestation in the carotid artery in high-risk hypertensive patients. Arterioscler Thromb. 1994;14:1297-1304.
16. Hulthe J, Wikstrand J, Emanuelsson H, Wiklund O, de-Feyter PJ, Wendelhag I. Atherosclerotic changes in the carotid artery bulb as measured by B-mode ultrasound are associated with the extent of coronary atherosclerosis. Stroke. 1997;28:1189-1194.
17. Suurküla M, Agewall S, Fagerberg B, Wendelhag I, Wikstrand J. Multiple intervention in high-risk hypertensive patients: a 3-year ultrasound study of intima-media thickness and plaques in the carotid artery. Arterioscler Thromb Vasc Biol. 1996;16:462-470.
18. Rosfors S, Hallerstam S, Urstad-Jensen K, Zetterling M, Carlström C. Relationship between intima-media thickness in the carotid artery and atherosclerosis in the carotid bifurcation. Stroke. 1998;29:1378-1382.
19. Bots ML, Hoes AW, Hofman A, Witteman JCM, Groebbee DE. Cross-sectionally assessed carotid intima-media thickness relates to long term risk of stroke, coronary heart disease and death as estimated by available risk functions. J Intern Med. 1999;245:269-276.
20. O'Leary DH, Polak JF, Kronmal RA, Manolio TA, Burke GL, Wolfson SK. Carotid artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. N Engl J Med. 1999;340: 14-22.
21. Fagerberg B, Wikstrand J, Berglund G, Samuelsson O, Agewall S. Mortality rates in treated hypertensive men with additional risk factors are high but can be reduced: a randomized intervention study. Am J Hypertens. 1998;11:14-22.
22. Wendelhag I, Liang Q, Gustavsson T, Wikstrand J. A new computerized analysing system simplifies readings and reduces the variability in ultrasound measurement of intima-media thickness. Stroke. 1997;28: 2195-2200.
23. Gibbs RGJ, Carey N, Davies AH. Chlamydia pneumoniae and vascular disease. Br J Surg. 1998;85:1191-1197.
24. Grayston JT, Kuo C-c, Campbell LA, Benditt EP. Chlamydia pneumoniae, strain TWAR and atherosclerosis. Eur Heart J. 1993;14(suppl K):S66-S71.
25. Grayston JT, Kuo C-c, Coulson AS, Campbell LA, Lawrence RD, Lee MJ, Strandness ED, Wang S-p. Chlamydia pneumoniae (TWAR) in atherosclerosis in the carotid artery. Circulation. 1995;92:3397-3400.
26. Wimmer MLJ, Sandmann-Strupp R, Saikku P, Harbel RL. Association of chlamydial infection with cerebrovascular disease. Stroke. 1996;27: 2207-2210.
27. Ekman MR, Leinonen M, Syrjälä H, Linnanmäki E, Kujala P, Saikku P. Evaluation of serological methods in the diagnosis of Chlamydia pneumoniae during an epidemic in Finland. Eur J Clin Microbiol Infect Dis. 1993;12:756-760.
28. O'Leary DH, Polak JF, Kronmal RA, Kittner SJ, Bond MG, Wolfson SK Jr, Bommer V, Price TR, Gardin JM, Savage PJ. Distribution and correlates of sonographically detected carotid artery disease in the Cardiovascular Health Study. Stroke. 1992;23:1752-1760.
29. Manami T, Konishi M, Baba S, Nishi N, Terao A. Prevalence of asymptomatic carotid atherosclerotic lesions detected by high-resolution ultrasonography and its relation to cardiovascular risk factors in the general population of a Japanese city: the Suita study. Stroke. 1997;28:518-525.
30. Bots ML, Breslau PJ, Briet E, de Bruyn AM, van Vliet HH, van den Ouweland FA, de Jong PT, Hofman A, Grobbee DE. Cardiovascular determinants of carotid artery disease: the Rotterdam Elderly Study. Hypertension. 1992;19:717-720.
31. Burke GL, Evans GW, Riley WA, Sharrett AR, Howard G, Barnes RW, Rosamond W, Crow RS, Rautaharju PM, Heiss G, for the ARIC Study Group. Arterial wall thickness is associated with prevalent cardiovascular disease in middle-aged adults: the Atherosclerosis Risk in Communities (ARIC) Study. Stroke. 1995;26:386-391.
32. Allan PL, Mowbray PI, Lee AJ, Fowkes FG. Relationship between carotid intima-media thickness and symptomatic and asymptomatic peripheral arterial disease: the Edinburgh Artery Study. Stroke. 1997;28: 348-353.
33. Salonen JT, Salonen R. Ultrasonographically assessed carotid morphology and the risk of coronary heart disease. Arterioscler Thromb. 1991;11:1245-1249.
34. Chambless LE, Heiss G, Folsom AR, Rosamond W, Szklo M, Sharrett AR, Clegg LX. Association of coronary heart disease incidence with carotid arterial wall thickness and major risk factors: the Atherosclerosis Risk in Communities (ARIC) Study, 1987-1993. Am J Epidemiol. 1997; 146:483-494.
35. Hodis HN, Mack WJ, LaBree L, Selzer RH, Liu CR, Liu CH, Azen SP. The role of carotid artery intima-media thickness in predicting clinical coronary events. Ann Intern Med. 1998;128:262-269.
36. Mayr M, Metzler B, Kiechl S, Willeit JW, Schett G, Xu Q, Wick G. Endothelial cytotoxicity mediated by serum antibodies to heat shock proteins of Escherichia coli and Chlamydia pneumoniae. Circulation. 1999;99:1560-1566.
37. Melnick SL, Shahar E, Folsom AR, Grayston JT, Sorlie PD, Wang S-p, Szklo M. Chlamydia pneumoniae strain TWAR and asymptomatic carotid atherosclerosis. Am J Med. 1993;95:499-504.
38. Ward ME. The immunobiology and immunopathology of chlamydial infections. APMIS. 1995;103:769-796.
39. Krüll M, Klucken AC, Wuppermann FN, Fuhrmann O, Magerl C, Seybold J, Hippenstiel S, Hegemann JH, Jantos CA, Suttorp N. Signal transduction pathways activated in endothelial cells following infection with Chlamydia pneumoniae. J Immunol. 1999;12:4834-4841.
40. Kalayoglu MV, Byrne GI. Induction of macrophage foam cell formation by Chlamydia pneumoniae. J Infect Dis. 1998;177:725-729.
41. Altman R, Rouvier J, Scazziota A, Absi RS, Gonzalez C. Lack of association between prior infection with Chlamydia pneumoniae and acute or chronic coronary artery disease. Clin Cardiol. 1999;22:85-90.